Gentian Diagnostics Valuation

Is 6FK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6FK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6FK (€3.56) is trading above our estimate of fair value (€1.15)

Significantly Below Fair Value: 6FK is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6FK?

Other financial metrics that can be useful for relative valuation.

6FK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.8x
Enterprise Value/EBITDA60.1x
PEG Ratio8.5x

Price to Sales Ratio vs Peers

How does 6FK's PS Ratio compare to its peers?

The above table shows the PS ratio for 6FK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.1x
PHH2 Paul Hartmann
0.3xn/a€724.6m
PUS PULSION Medical Systems
3.7xn/a€132.7m
AAQ1 aap Implantate
1.9xn/a€22.2m
M3V MeVis Medical Solutions
2.5xn/a€44.4m
6FK Gentian Diagnostics
4.4x24.6%€672.4m

Price-To-Sales vs Peers: 6FK is expensive based on its Price-To-Sales Ratio (4.4x) compared to the peer average (2.1x).


Price to Earnings Ratio vs Industry

How does 6FK's PE Ratio compare vs other companies in the DE Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.7%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.7%
n/an/an/a
No more companies

Price-To-Sales vs Industry: 6FK is expensive based on its Price-To-Sales Ratio (4.4x) compared to the European Medical Equipment industry average (3.7x).


Price to Sales Ratio vs Fair Ratio

What is 6FK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6FK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.4x
Fair PS Ratio2x

Price-To-Sales vs Fair Ratio: 6FK is expensive based on its Price-To-Sales Ratio (4.4x) compared to the estimated Fair Price-To-Sales Ratio (2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies